Literature DB >> 19647814

Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice.

Shigefumi Okamoto1, Masaaki Matsuura, Takami Akagi, Mitsuru Akashi, Takeshi Tanimoto, Toyokazu Ishikawa, Michiaki Takahashi, Koichi Yamanishi, Yasuko Mori.   

Abstract

Adding poly(gamma-glutamic acid) nano-particles (gamma-PGA-NPs), a safe, natural material, to subcutaneous immunization with influenza virus hemagglutinin (HA) vaccine increases the protective immune responses against influenza virus in mice. Here, we examined whether intranasal administration of the HA vaccine with gamma-PGA-NPs would induce protection from influenza virus challenge in mice. Intranasal immunization with the mixture of gamma-PGA-NPs and HA vaccine from an influenza virus strain A/PR/8/34 (H1N1) or A/New Caledonia/20/99 (H1N1) enhanced protection of mice from A/PR/8/34 infection. Intranasal immunization with A/New Caledonia/20/99 HA vaccine and gamma-PGA-NPs induced cell-mediated immune responses and neutralizing antibody production for both A/New Caledonia/20/99 and A/PR/8/34. These data suggest that gamma-PGA-NPs may have potential for clinical applications as a mucosal adjuvant.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19647814     DOI: 10.1016/j.vaccine.2009.07.037

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

1.  Uptake of biodegradable poly(γ-glutamic acid) nanoparticles and antigen presentation by dendritic cells in vivo.

Authors:  Tomofumi Uto; Masaaki Toyama; Yosuke Nishi; Takami Akagi; Fumiaki Shima; Mitsuru Akashi; Masanori Baba
Journal:  Results Immunol       Date:  2012-12-03

2.  Biomedical Applications of Biodegradable Polymers.

Authors:  Bret D Ulery; Lakshmi S Nair; Cato T Laurencin
Journal:  J Polym Sci B Polym Phys       Date:  2011-06-15

3.  Intranasal immunization with a formalin-inactivated human influenza A virus whole-virion vaccine alone and intranasal immunization with a split-virion vaccine with mucosal adjuvants show similar levels of cross-protection.

Authors:  Shigefumi Okamoto; Sumiko Matsuoka; Nobuyuki Takenaka; Ahmad M Haredy; Takeshi Tanimoto; Yasuyuki Gomi; Toyokazu Ishikawa; Takami Akagi; Mitsuru Akashi; Yoshinobu Okuno; Yasuko Mori; Koichi Yamanishi
Journal:  Clin Vaccine Immunol       Date:  2012-05-02

4.  Toll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats.

Authors:  Liesu Meng; Wenhua Zhu; Congshan Jiang; Xiaojing He; Weikun Hou; Fang Zheng; Rikard Holmdahl; Shemin Lu
Journal:  Arthritis Res Ther       Date:  2010-05-25       Impact factor: 5.156

5.  Chitosan nanoparticle encapsulated hemagglutinin-split influenza virus mucosal vaccine.

Authors:  Chompoonuch Sawaengsak; Yasuko Mori; Koichi Yamanishi; Ampol Mitrevej; Nuttanan Sinchaipanid
Journal:  AAPS PharmSciTech       Date:  2013-12-17       Impact factor: 3.246

6.  An MDCK cell culture-derived formalin-inactivated influenza virus whole-virion vaccine from an influenza virus library confers cross-protective immunity by intranasal administration in mice.

Authors:  Ahmad M Haredy; Nobuyuki Takenaka; Hiroshi Yamada; Yoshihiro Sakoda; Masatoshi Okamatsu; Naoki Yamamoto; Takeshi Omasa; Hisao Ohtake; Yasuko Mori; Hiroshi Kida; Koichi Yamanishi; Shigefumi Okamoto
Journal:  Clin Vaccine Immunol       Date:  2013-05-01

7.  Intranasal administration of poly-gamma glutamate induced antiviral activity and protective immune responses against H1N1 influenza A virus infection.

Authors:  Eun-Ha Kim; Young-Ki Choi; Chul-Joong Kim; Moon-Hee Sung; Haryoung Poo
Journal:  Virol J       Date:  2015-10-06       Impact factor: 4.099

8.  Raspberry-like poly(γ-glutamic acid) hydrogel particles for pH-dependent cell membrane passage and controlled cytosolic delivery of antitumor drugs.

Authors:  Sun-Hee Cho; Ji Hyeon Hong; Young-Woock Noh; Eunji Lee; Chang-Soo Lee; Yong Taik Lim
Journal:  Int J Nanomedicine       Date:  2016-10-27

9.  Poly-γ-glutamic acid/chitosan nanogel greatly enhances the efficacy and heterosubtypic cross-reactivity of H1N1 pandemic influenza vaccine.

Authors:  Jihyun Yang; Sang-Mu Shim; Thi Quyen Nguyen; Eun-Ha Kim; Kwang Kim; Yong Taik Lim; Moon-Hee Sung; Richard Webby; Haryoung Poo
Journal:  Sci Rep       Date:  2017-03-21       Impact factor: 4.379

Review 10.  Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID).

Authors:  Amir Seyfoori; Mahdieh Shokrollahi Barough; Pooneh Mokarram; Mazaher Ahmadi; Parvaneh Mehrbod; Alireza Sheidary; Tayyebeh Madrakian; Mohammad Kiumarsi; Tavia Walsh; Kielan D McAlinden; Chandra C Ghosh; Pawan Sharma; Amir A Zeki; Saeid Ghavami; Mohsen Akbari
Journal:  Int J Mol Sci       Date:  2021-06-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.